Indian clinical practice consensus guidelines for the management of laryngeal cancer: Update 2022

• Published in: Cancer research, statistics, and treatment (Online) Vol. 7; no. Suppl 1; pp. S22 - S26
• Main Authors: Singhal, Manish, Prabhash, Kumar, Babu, K. Govind, Chaturvedi, Pankaj, Kuriakose, Moni, Birur, Praveen, Anand, Anil K., Kaushal, Ashish, Mahajan, Abhishek, Syiemlieh, Judita, Gairola, Munish, Ramachandra, Prakash, Goyal, Sumit, John, Subashini, Nayyar, Rohit, Patil, Vijay M., Rao, Vishal, Noronha, Vanita, Roshan, Vikas, Rath, G. K.
• Format: Journal Article
• Language: English
• Published: India Wolters Kluwer - Medknow 01.01.2024
• Edition: 2
• Subjects: Special Article; consensus; Indian guidelines; laryngeal cancer; laryngeal preservation larynx; Chemoradiation; organ preservation
• ISSN: 2590-3233; 2590-3225
• DOI: 10.4103/crst.crst_122_23

In laryngeal cancer, the goal of treatment is to achieve maximum cure and preserve function of the larynx with good voice quality. In early disease, transoral laser microsurgery is the preferred choice of treatment. An option for treatment of carcinoma in situ is radiotherapy (RT). In locally advanced laryngeal carcinoma, concurrent chemoradiotherapy (CTRT) is an option. Induction therapy with docetaxel, cisplatin, and 5-flourouracil (TPF), followed by definitive RT or definitive CTRT can be one of the organ preservation approaches for patients undergoing total laryngectomy. For resectable locally advanced disease (T3, N0-3), surgery (laryngectomy with thyroidectomy, ipsilateral or bilateral neck dissection, and pretracheal and ipsilateral paratracheal lymph node dissection) with RT or CTRT should be considered.